Capital International Investors 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-10 11:58 am Purchase | 2024-04-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 8,223,994 10.200% | 1,803,258 (+28.08%) | Filing |
| 2024-02-09 6:03 pm Purchase | 2024-02-07 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 6,420,736 8.100% | 860,244 (+15.47%) | Filing |
| 2023-02-13 3:54 pm Purchase | 2023-02-14 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 5,560,492 7.100% | 1,854,488 (+50.04%) | Filing |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 3,706,004 4.800% | -558,998 (-13.11%) | Filing |
| 2021-08-10 12:28 pm Sale | 2021-08-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 4,265,002 5.600% | -3,361,353 (-44.08%) | Filing |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 7,626,355 10.700% | 106,552 (+1.42%) | Filing |
| 2020-09-11 11:04 am Unchanged | 2020-09-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 7,519,803 10.700% | 0 (Unchanged) | Filing |
| 2020-09-10 2:54 pm Purchase | 2020-09-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 7,519,803 10.700% | 7,519,803 (New Position) | Filing |